Effect of 2-chloro-substitution of adenine moiety in mixed-ligand gold(I) triphenylphosphine complexes on anti-inflammatory activity: The discrepancy between the in vivo and in vitro models

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Hošek, Jan ^a   Vančo, Ján ^a   Štarha, Pavel ^a   Paráková, Lenka ^b   Trávníček, Zdeněk ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CYTOKINES; EDEMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GOLD; LIGANDS; ORGANOPHOSPHORUS COMPOUNDS; RATS; RATS, WISTAR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84894263047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082441     Document Type: Article

References (55)

1. Pradal A, Toullec PY, Michelet V (2011) Recent developments in asymmetric catalysis in the presence of chiral gold complexes. Synthesis 10: 1501-1514.
2. Cao ZY, Wang XM, Tan C, Zhao XL, Zhou J et al. (2013) Highly stereoselective olefin cyclopropanation of diazooxindoles catalyzed by a C-2-symmetric spiroketal bisphosphine/Au(I) complex. J Am Chem Soc 135: 8197-8200. doi:10.1021/ja4040895.
3. Liu B, Li KN, Luo SW, Huang JZ, Pang H et al. (2013) Chiral gold complex-catalyzed hetero-diels-alder reaction of diazenes: highly enantioselective and general for dienes. J Am Chem Soc 135: 3323-3326. doi:10.1021/ja3110472. PubMed: 23421493.
4. Jungwirth U, Kowol CR, Keppler BK, Hartinger CG, Berger W et al. (2011) Anticancer activity of metal complexes: involvement of redox processes. Antioxid Redox Signal 15: 1085-1127. doi:10.1089/ars. 2010.3663. PubMed: 21275772.
5. Ott I, Qian X, Xu Y, Vlecken DHW, Marques IJ et al. (2009) A gold(I) phosphine complex containing a naphthalimide ligand functions as a TrxR inhibiting antiproliferative agent and angiogenesis inhibitor. J Med Chem 52: 763-770. doi:10.1021/jm8012135. PubMed: 19123857.
6. Lima JC, Rodriguez L (2011) Phosphine-gold(I) compounds as anticancer agents: general description and mechanisms of action. Anticancer Agents Med Chem 11: 921-928. doi:10.2174/187152011797927670. PubMed: 21864238.
7. Navarro M (2009) Gold complexes as potential anti-parasitic agents. Coord Chem Rev 253: 1619-1626. doi:10.1016/j.ccr.2008.12.003.
8. Gielen M, Tiekink ERT (2005) Metallotherapeutic drugs and metal-based diagnostic agents. London: Willey.
9. Ott I (2009) On the medicinal chemistry of gold complexes as anticancer drugs. Coord Chem Rev 253: 1670-1681. doi:10.1016/j.ccr. 2009.02.019.
10. Trávníček Z, Starha P, Vančo J, Silha T, Hošek J et al. (2012) Anti-inflammatory active gold(I) complexes involving 6-substituted purine derivatives. J Med Chem 55: 4568-4579. doi:10.1021/jm201416p. PubMed: 22541000.
11. von Nägeli CW, Schwendener S, Cramer C (1893) Ueber oligodynamische Erscheinungen in lebenden Zellen. Zürich: Druck von Zürcher und Furrer: 51.
12. Kostova I (2006) Gold coordination complexes as anticancer agents. Anticancer Agents Med Chem 6: 19-32. doi:10.2174/187152006774755500. PubMed: 16475924.
13. Buac D, Schmitt S, Ventro G, Kona FR, Dou QP (2012) Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells. Mini Rev Med Chem 12: 1193-1201. doi:10.2174/138955712802762040. PubMed: 22931591.
14. Hoke GD, Rush GF, Bossard GF, McArdle JV, Jensen BD et al. (1988) Mechanism of alterations in isolated rat liver mitochondrial function induced by gold complexes of bidentate phosphines. J Biol Chem 263: 11203-11210. PubMed: 2457018.
15. Hoke GD, Rush GF, Mirabelli CK (1989) The mechanism of acute cytotoxicity of triethylphosphine gold(I) complexes. III. Chlorotriethylphosphine gold(I)-induced alterations in isolated rat liver mitochondrial function. Toxicol Appl Pharmacol 99: 50-60. doi:10.1016/0041-008X(89)90110-5. PubMed: 2471292.
16. Rackham O, Nichols SJ, Leedman PJ, Berners-Price SJ, Filipovska A (2007) A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria. Biochem Pharmacol 74: 992-1002. doi:10.1016/j.bcp. 2007.07.022. PubMed: 17697672.
17. Hoke GD, McCabe FL, Faucette LF, Bartus JO, Sung CM et al. (1991) In vivo development and in vitro characterization of a subclone of murine P388 leukemia resistant to bis(diphenylphosphine)ethane. Mol Pharmacol 39: 90-97. PubMed: 1898982.
18. Smith PF, Hoke GD, Alberts DW, Bugelski PJ, Lupo S et al. (1989) Mechanism of toxicity of an experimental bidentate phosphine gold complexed antineoplastic agent in isolated rat hepatocytes. J Pharmacol Exp Ther 249: 944-950. PubMed: 2732955.
19. Gandin V, Fernandes AP, Rigobello MP, Dani B, Sorrentino F et al. (2010) Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Biochem Pharmacol 79: 90-101. doi:10.1016/j.bcp.2009.07.023. PubMed: 19665452.
20. Tonissen KF, Di Trapani G (2009) Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy. Mol Nutr Food Res 53: 87-103. doi:10.1002/mnfr.200700492. PubMed: 18979503.
21. Vergara E, Casini A, Sorrentino F, Zava O, Cerrada E et al. (2010) Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands. Chemmedchem 5: 96-102. doi:10.1002/cmdc. 200900370. PubMed: 19937669.
22. Lee MT, Ahmed T, Haddad R, Friedman ME (1989) Inhibition of several enzymes by gold compounds. II. Beta-glucuronidase, acid phosphatase and L-malate dehydrogenase by sodium thiomalatoraurate(I), sodium thiosulfatoaurate(I) and thioglucosoaurate(I). J Enzyme Inhib 3: 35-47
23. Hedström E, Eriksson S, Zawacka-Pankau J, Arnér ES, Selivanova G (2009) p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA. Cell Cycle 8: 3576-3583. PubMed: 19838062.
24. Kim NH, Oh MK, Park HJ, Kim IS (2010) Auranofin, a gold(I)-containing antirheumatic compound, activates Keap1/Nrf2 signaling via Rac1/iNOS signal and mitogen-activated protein kinase activation. J Pharmacol Sci 113: 246-254. doi:10.1254/jphs.09330FP. PubMed: 20647686.
25. Jeon KI, Byun MS, Jue DM (2003) Gold compound auranofin inhibits IkappaB kinase (IKK) by modifying Cys-179 of IKKbeta subunit. Exp Mol Med 35: 61-66. doi:10.1038/emm.2003.9. PubMed: 12754408.
26. Kim NH, Lee MY, Park SJ, Choi JS, Oh MK et al. (2007) Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3. Immunology 122: 607-614. doi:10.1111/j. 1365-2567.2007.02679.x. PubMed: 17645497.
27. Youn HS, Lee JY, Saitoh SI, Miyake K, Hwang DH (2006) Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Biochem Biophys Res Commun 350: 866-871. doi:10.1016/j.bbrc.2006.09.097. PubMed: 17034761.
28. Williams HJ, Ward JR, Reading JC, Brooks RH, Clegg DO et al. (1992) Comparison of auranofin, methotreaxate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 35: 259-269. doi:10.1002/art.1780350304. PubMed: 1536666.
29. Sorenson JRJ (1976) Copper chelates as possible active forms of the antiarthritic agents. J Med Chem 19: 135-148. doi:10.1021/jm00223a024. PubMed: 1246036.
30. 2] complexes. J Inorg Biochem 98: 1734-1749
31. Oh CH, Lee SC, Lee KS, Woo ER, Hong CY et al. (1999) Synthesis and biological activities of C-2, N-9 substituted 6-benzylaminopurine derivatives as cyclin-dependent kinase inhibitor. Arch Pharm (Weinheim) 332: 187-190. doi:10.1002/(SICI)1521-4184(19996)332:6. PubMed: 10399486.
32. Mann FG, Wells AF, Purdie D (1937) The constitution of complex metallic salts. Part VI. The constitution of the phosphine and arsine derivatives of silver and aurous halides. The configuration of the coordinated argentous and aurous complex. J Chem Soc: 1828-1836. doi:10.1039/jr9370001828.
33. Bruce MI, Nicholson BK, Shawkataly bin O, Shapley JR, Henly T (1989) Synthesis of gold-containing mixed-metal cluster complexes. Inorg Syn 26: 324-328
34. Schöniger W (1956) Die mikroanalytische schnellbestimmung von halogen und schwefel in organischen verbindungen. Mikrochim Acta 44: 869-876. doi:10.1007/BF01262130.
35. Pěnčíkova K, Kollár P, Müller Závalová V, Táborská E, Urbanová J et al. (2012) Investigation of sanguinarine and chelerythrine effects on LPS-induced inflammatory gene expression in THP-1 cell line. Phytomedicine 19: 890-895. doi:10.1016/j.phymed.2012.04.001. PubMed: 22592163.
36. Talhouk RS, Chin JR, Unemori EN, Werb Z, Bissell MJ (1991) Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development 112: 439-449. PubMed: 1794314.
37. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110. doi:10.1016/0304-3959(83)90201-4. PubMed: 6877845.
38. Kiernan JA (2008) Histological and histochemical methods: theory and practice. 4th ed. Bloxham, UK: Scion.
39. Geary WJ (1971) The use of conductivity measurements in organic solvents for the characterisation of coordination compounds. Coord Chem Rev 7: 81-122. doi:10.1016/S0010-8545(00)80009-0.
40. Pouchert CJ (1981) The Aldrich library of infrared spectra. Aldrich Chemical Company Press, Milwaukee.
41. Čajan M, Trávníček Z (2011) Structural (X-ray), spectral (FT-IR and Raman) and quantum chemical investigations of a series of 6-benzylaminopurine derivatives. J Mol Struct 994: 350-359. doi:10.1016/j.molstruc.2011.03.049.
42. Maćkowiak M, Kolasiewicz W, Markowicz-Kula K, Wedzony K (2005) Purvalanol A, inhibitor of cyclin-dependent kinases attenuates proliferation of cells in the dentate gyrus of the adult rat hippocampus. Pharmacol Rep 57: 845-849. PubMed: 16382206.
43. Nomiya K, Noguchi R, Ohsawa K, Tsuda K, Oda M (2000) Synthesis, crystal structure and antimicrobial activities of two isomeric gold(I) complexes with nitrogen-containing heterocycle and triphenylphosphine ligands, [Au(L)(PPh3)] (HL = pyrazole and imidazole). J Inorg Biochem 78: 363-370. doi:10.1016/S0162- 0134(00)00065-9. PubMed: 10857918.
44. 2. J Organomet Chem 518: 121-138
45. 2mna = 6-mercaptonicotinic acid). J Inorg Biochem 95: 208-220. doi:10.1016/S0162-0134(03)00125-9. PubMed: 12763666.
46. Demirovic D, Rattan SI (2013) Establishing cellular stress response profiles as biomarkers of homeodynamics, health and hormesis. Exp Gerontol 48: 94-98. doi:10.1016/j.exger.2012.02.005. PubMed: 22525591.
47. Seitz M, Valbracht J, Quach J, Lotz M (2003) Gold sodium thiomalate and chloroquine inhibit cytokine production in monocytic THP-1 cells through distinct transcriptional and posttranslational mechanisms. J Clin Immunol 23: 477-484. doi:10.1023/B:JOCI.0000010424.41475.17. PubMed: 15031635.
48. 2O. Inorg Chem 47: 6262-6272. doi:10.1021/ic800314p. PubMed: 18563877.
49. Coppi G, Borella F, Gatti MT, Comini A, Dall'Asta L (1989) Synthesis, antiinflammatory and antiarthritic properties of a new tiopronine gold derivative. Boll Chim Farm 128: 22-24. PubMed: 2775517.
50. Girard GR, Hill DT, Dimartino MJ (1989) Evaluation of some tetraalkylammonium gold(I) and gold(III) aurate salts for oral antiinflammatory and antiarthrithic activity. Inorg Chim Acta 166: 141-146. doi:10.1016/S0020- 1693(00)80799-9.
51. Shaw CF, Coffer MT, Klingbeil J, Mirabelli CK (1988) Application of phosphorus-31 NMR chemical shift: gold affinity correlation to hemoglobin-gold binding and the first inter-protein gold transfer reaction. J Am Chem Soc 110: 729-734. doi:10.1021/ja00211a011.
52. Iqbal MS, Taqi SG, Arif M, Wasim M, Sher M (2009) In vitro distribution of gold in serum proteins after incubation of sodium aurothiomalate and auranofin with human blood and its pharmacological significance. Biol Trace Elem Res 130: 204-209. doi:10.1007/s12011-009-8330-0. PubMed: 19194667.
53. Saccoccia F, Angelucci F, Boumis G, Brunori M, Miele AE et al. (2012) On the mechanism and rate of gold incorporation into thiol-dependent flavoreductases. J Inorg Biochem 108: 105-111. doi:10.1016/j.jinorgbio.2011.11. 005. PubMed: 22166353.
54. Lewis D, Capell HA, McNeil CJ, Iqbal MS, Brown DH et al. (1983) Gold levels produced by treatment with auranofin and sodium aurothiomalate. Ann Rheum Dis 42: 566-570. doi:10.1136/ard. 42.5.566. PubMed: 6414387.
55. Salemi G, Gueli MC, D'Amelio M, Saia V, Mangiapane P et al. (2009) Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B12 in the acute phase of atherothrombotic stroke. Neurol Sci 30: 361-364. doi:10.1007/s10072-009-0090-2. PubMed: 19484186.